Reimbursed with a limitationOriginator productATC C09DX03

Sevikar HCT

Sevikar HCT is an originator product from Daiichi Sankyo (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 33.20 to CHF 81.90 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Daiichi Sankyo (Schweiz) AG
ATC code
C09DX03
IT group
02.07.20 Kombinierte blutdrucksenkende Mittel
Active substances
Olmesartani medoxomilum, Amlodipinum, Hydrochlorothiazidum
Preparation type
Originator product
On the SL since
01/08/2011
Last price change
01/12/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Sevikar HCT Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 20/5/12.5 mg28 StkCHF 15.54CHF 33.2001/08/2011B7680615190018
Filmtabl 20/5/12.5 mg98 StkCHF 44.39CHF 64.3001/08/2011B7680615190025
Filmtabl 40/5/12.5 mg28 StkCHF 19.23CHF 37.2001/08/2011B7680615190032
Filmtabl 40/5/12.5 mg98 StkCHF 55.32CHF 76.1001/08/2011B7680615190049
Filmtabl 40/10/12.5 mg28 StkCHF 20.04CHF 38.0501/08/2011B7680615190056
Filmtabl 40/10/12.5 mg98 StkCHF 60.71CHF 81.9001/08/2011B7680615190063
Filmtabl 40/5/25 mg28 StkCHF 19.23CHF 37.2001/08/2011B7680615190070
Filmtabl 40/5/25 mg98 StkCHF 55.32CHF 76.1001/08/2011B7680615190087
Filmtabl 40/10/25 mg28 StkCHF 20.04CHF 38.0501/08/2011B7680615190094
Filmtabl 40/10/25 mg98 StkCHF 60.71CHF 81.9001/08/2011B7680615190100

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/10/2025

Die gleichzeitige Therapie mit SEVIKAR/HCT und einem Calciumantagonisten des I.T. 02.06. und/oder einem Angiotensin-II-Antagonisten und/oder einem ACE-Hemmer wird von der obligatorischen Krankenpflegeversicherung nicht vergütet.

More preparations in this group

FAQ

Is Sevikar HCT covered by Swiss health insurance?

Yes, but only under conditions. Sevikar HCT is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Sevikar HCT cost in Switzerland?

The public price is the maximum price set by the FOPH and for Sevikar HCT ranges from CHF 33.20 to CHF 81.90 per pack. The ex-factory price ranges from CHF 15.54 to CHF 60.71. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com